Mark Gelbert has served as our Chief Scientific Officer since October 2017. In this role, he leads the Company’s research, development and innovation efforts across all of its global brands.
Before joining The Bountiful Company, Dr. Gelbert served as Senior Vice President of Global R&D for Pfizer’s Consumer Healthcare division and as a member of its Global Leadership Team from October 2009 to October 2015. Previously, he held R&D leadership roles including Vice President of Global R&D at Johnson & Johnson (2006 to 2009), Vice President of Global R&D at Pfizer Consumer Healthcare (2002 to 2006), Vice President Scientific Affairs at Schering-Plough Healthcare (1999 to 2002), and Vice President R&D North America at Novartis Consumer Healthcare (1993 to 1999). Dr. Gelbert began his career in Product Development as a Staff Scientist at Procter & Gamble (1985 to 1993).
He has held leadership positions in a number of professional organizations, including the Consumer Healthcare Products Association, where he was Chair of the Scientific Affairs Committee and a member of the board of directors (1998 to 2002). Dr. Gelbert currently serves on the Rutgers University Chemistry and Chemical Biology Advisory Board since 2015. He is admitted to the Ohio State Bar.
Dr. Gelbert has his Bachelor of Arts in Chemistry from Rutgers College, and a Masters of Science and PhD in Chemistry from the University of Massachusetts, Amherst. He also has his Juris Doctor from Salmon Chase College of Law.